Twist Bioscience Corporation
TWST
Rang in Aktien
#2192
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Aktienkurs
$139.73
Marktkapitalisierung
$9.20B
Veränderung (1 Tag)
-0.03%
Veränderung (1 Jahr)
326.78%
Land
US
Handel Twist Bioscience Corporation (TWST)
Kategorie
Healthcare
P/B-Verhältnis für Twist Bioscience Corporation (TWST)
P/B-Verhältnis zum October 2026 TTM: 20.74
Laut den neuesten Finanzberichten und dem Aktienkurs von Twist Bioscience Corporation beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 20.74. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 5.55.
P/B-Verlauf für Twist Bioscience Corporation von 2016 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 20.74 | 482.65% |
| 2025 | 3.56 | -35.83% |
| 2024 | 5.55 | 199.97% |
| 2023 | 1.85 | -23.15% |
| 2022 | 2.41 | -72.93% |
| 2021 | 8.89 | 0.37% |
| 2020 | 8.85 | 105.33% |
| 2019 | 4.31 | -333.15% |
| 2018 | -1.85 | -6.19% |
| 2017 | -1.97 | -42.55% |
| 2016 | -3.43 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 4.7411 | -77.14% |
US
|
|
| 3.0143 | -85.47% |
US
|
|
| 31.051 | 49.70% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -67.87% |
US
|
